Daptomycin Side Effects
How can Daptomycin Side Effects affect You? | PatientsVille.com
View and Submit Daptomycin Side Effects
Your Daptomycin Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Side Effects reported to FDA: 197. View Daptomycin Adverse Reports
Reported deaths: 7
Reported hospitalizations: 83
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
AUDIENCE: Infectious Disease, Pulmonology
ISSUE: FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug indicated for use in treatment of serious skin infections and bloodstream infections. Eosinophilic pneumonia is a rare but serious condition where a type of white blood cell (eosinophil) fills the lungs. Symptoms of eosinophilic pneumonia include fever, cough, shortness of breath, and difficulty breathing. Eosinophilic pneumonia may lead to progressive respiratory failure and is potentially fatal if not quickly recognized and appropriately managed.
BACKGROUND: FDA has reviewed published case reports of Cubicin-associated eosinophilic pneumonia and conducted a review of post-marketing adverse event reports from the FDA's Adverse Event Reporting System. FDA's review identified 7 cases of eosinophilic pneumonia between 2004 and 2010 that were most likely associated with Cubicin. Based on these reviews, FDA determined that eosinophilic pneumonia can be associated with Cubicin use and requested that the manufacturer of Cubicin include this information in the Warnings and Precautions and Adverse Reactions, Post-Marketing Experience sections of the drug label.
RECOMMENDATION: Healthcare professionals should closely monitor patients being treated with Cubicin for eosinophilic pneumonia. Patients receiving Cubicin should immediately contact their healthcare professional if they develop a new or worsening fever, cough, shortness of breath, or difficulty breathing.
Additional information for Healthcare Professionals, Information for Patients, a Data Summary, and References are provided in the Drug Safety Communication at the link below.
Did You Have a Daptomycin Side Effect?
How Effective is Daptomycin for You?
Daptomycin Adverse Reactions
Blood Creatine Phosphokinase Increased ( 43 Reports)|Rhabdomyolysis ( 32 Reports)|Eosinophilic Pneumonia ( 22 Reports)|Dyspnoea ( 13 Reports)|Pyrexia ( 13 Reports)|Eosinophilia ( 9 Reports)|Rash ( 9 Reports)|Blood Creatinine Increased ( 7 Reports)|Lung Infiltration ( 7 Reports)|Myalgia ( 7 Reports)|Renal Failure Acute ( 7 Reports)|Eosinophil Count Increased ( 6 Reports)|Infection ( 6 Reports)|Pain ( 6 Reports)|Pruritus ( 6 Reports)|Anaphylactic Shock ( 5 Reports)|Pneumonitis ( 5 Reports)|Fall ( 4 Reports)|Fatigue ( 4 Reports)|Haemodialysis ( 4 Reports)|Nausea ( 4 Reports)|Oedema Peripheral ( 4 Reports)|Pleural Effusion ( 4 Reports)|Renal Failure ( 4 Reports)|Respiratory Distress ( 4 Reports)|Alveolitis Allergic ( 3 Reports)|Arthralgia ( 3 Reports)|Aspartate Aminotransferase Increased ( 3 Reports)|Blood Potassium Increased ( 3 Reports)|Dialysis ( 3 Reports)|